3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
2
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Urologic Neoplasms
1
Stomach Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Interventions
Gemcitabine
3
sargramostim
2
pertuzumab
2
binimetinib
2
Trastuzumab
2
Specimen Handling
2
Polymerase Chain Reaction
2
Paclitaxel
2
Nicotine
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
Counseling
2
Bupropion
2
Azacitidine
2
vandetanib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
tanespimycin
1
sapanisertib
1
romidepsin
1
relatlimab
1
pembrolizumab
1
palbociclib
1
osimertinib
1
omipalisib
1
motexafin gadolinium
1
motesanib diphosphate
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Tissue Banks
×
Other hematologic neoplasm
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled